Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 174-182 , November 2005

Comparison of the quality of diabetes care in primary care diabetic clinics and general practice clinics

  • K.A.J. Al Khaja

      Affiliations

    • Department of Pharmacology and Therapeutics, Arabian Gulf University, P.O. Box 22979, Manama, Kingdom of Bahrain
    • Corresponding Author InformationCorresponding author. Tel.: +973 3 9644642; fax: +973 17 271090.
    • ,
  • R.P. Sequeira

      Affiliations

    • Department of Pharmacology and Therapeutics, Arabian Gulf University, P.O. Box 22979, Manama, Kingdom of Bahrain
    • ,
  • A.H.H. Damanhori

      Affiliations

    • Primary Care, Ministry of Health, Kingdom of Bahrain

Received 7 June 2004 ,Revised 28 October 2004 ,Accepted 16 March 2005.

References 

  1. Diabetes Atlas 2000, International Diabetes Federation, 2000.
  2. Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diab. Care. 2001;24:695–700
  3. Strumberg JP, Overend D. General practice based diabetes clinics: an integration model. Aust. Fam. Physician. 1999;28:240–245
  4. McCulloch DK, Price MJ, Hindmarsh M, Wagner EH. A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff. Clin. Pract. 1988;1:12–22
  5. Rosenqvist U, Carlson A, Luft R. Evaluation of a comprehensive programme for diabetes care at primary health-care level. Diab. Care. 1988;11:269–274
  6. Al Khaldi YM, Khan MY. Impact of a mini-clinic on diabetic care at a primary health care center in Southern Saudi Arabia. Saudi Med. J. 2002;23:51–55
  7. Reed RL, Revel AO, Carter A, Saadi HF, Dunn EV. A clinical trial of chronic care diabetic clinics in general practice in the United Arab Emirates: a preliminary analysis. Arch. Physiol. Biochem. 2001;109:272–280
  8. Griffin S. Diabetes care in general practice: meta analysis of randomized control trial. Br. Med. J. 1998;317:390–395
  9. Sequeira RP, Al Khaja KAJ, Damanhori AHH. Treatment of hypertension in diabetes mellitus: need for better control?. J. Eval. Clin. Pract. 2004;22:107–116
  10. Al Khaja KAJ, Sequeira RP, Damanhori AHH. Treatment of hypertension in Bahrain. Ann. Pharmacother. 2003;37:1511–1517
  11. Katayama S, Inaba M, Morita T, Awata T, Shimamato K, Kikkawa R. Blood pressure control in Japanese hypertensive with or without type 2 diabetes mellitus. Hypertens. Res. 2000;23:601–605
  12. Hanninen JA, Takala JK, Keinanen-Kiukaanniemi SM. Blood pressure control in subjects with type 2 diabetes. J. Hum. Hypertens. 2000;14:111–115
  13. United Kingdom Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, UKPDS 38, Br. Med. J. 317 (1998) 703–713.
  14. The Hypertension in Diabetes Study Group, Hypertension in Diabetes Study (HDS). I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications, J. Hypertens. 11 (1993) 309–317.
  15. Abraira C, Colwell JA, Nuttal FQ, Sawin CT, Negal NJ, Comstock JP, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VACSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in type II diabetes. Diab. Care. 1995;18:1113–1123
  16. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatients trial. Diab. Care. 1993;16:21–31
  17. Harris MI. Medical care for patients with diabetes. Epidemiologic aspects. Ann. Intern. Med. 1996;124:117–122
  18. Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. J. Am. Med. Assoc. 1997;278:1663–1669
  19. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 1999;131:281–303
  20. Al Khaja KAJ, Sequeira RP, Mathur VS, Damanhori AHH, Abdul Wahab AWM. Family physicians’ and general practitioners’ approaches to drug management of diabetic hypertension in primary care. J. Eval. Clin. Pract. 2002;8:19–30
  21. 1999 World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension, Guidelines Subcommittee, J. Hypertens. 17 (1999) 151–183.
  22. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 1991;325:373–381
  23. Stem MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 1986;6:123–130
  24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. J. Am. Med. Assoc. 2003;289:2560–2572
  25. 2003 European Society of Hypertension—European Society of Cardiology Guidelines for the management of arterial hypertension. Guidelines Committee, J. Hypertens. 21 (2003) 1011–1053.
  26. American Diabetic Association (ADA). Evidence-based nutrition: principles and recommendations for the treatment and prevention of diabetes and related complications. Positional statement, Diab. Care 26 (2003) S51–S61.
  27. Protocols and guidelines for nurse run diabetic clinic. Directorate of Health Centres, Primary Care, Ministry of Health, Kingdom of Bahrain, 2001.
  28. Davidson MB. Effect of nurse-directed diabetes care in a minority of population. Diab. Care. 2003;26:2281–2287

☆ The abstract of this paper was presented at the 14th European Meeting on Hypertension, 13–17 June 2004, Paris, France.

PII: S0168-8227(05)00123-3

doi: 10.1016/j.diabres.2005.03.029

Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 174-182 , November 2005

Article Tools